Continuous central haemodynamic measurements during the six-minute walk test and daily life in patients with chronic heart failure

European Journal of Heart Failure

Volumn 11, Issue 6, 2009, Pages 594-601

  Braunschweig, Frieder ^a   Linde, Cecilia ^a   Adamson, Philip B ^b   Magalski, Anthony ^c   Erdmann, Erland ^d   Kjellstrom, Barbro ^e   Bennett, Tom ^e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^d UNIVERSITY OF COLOGNE   (Germany)

^e MEDTRONIC INC   (United States)

Author keywords

6 min walk test; Congestive heart failure; Exercise; Haemodynamic monitoring; Haemodynamics

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART FAILURE; HEART RATE; HEART RIGHT VENTRICLE PRESSURE; HEMODYNAMIC MONITORING; HUMAN; LUNG ARTERY PRESSURE; MALE; MEASUREMENT; MOBILIZATION; MONITOR; PRIORITY JOURNAL; SIX MINUTE WALK TEST;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY WEDGE PRESSURE; TIME FACTORS; VENTRICULAR PRESSURE; WALKING;

EID: 68949136468     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfp045     Document Type: Article

References (34)

1. Cowie MR, Mosterd A, Wood DA, Deckers JW, Poole-Wilson PA, Sutton GC, Grobbee DE. The epidemiology of heart failure. Eur Heart J 1997;18:208-225.
2. Criteria Committee NYHA. Nomenclature and criteria for diagnosis. Diseases of the Heart and Blood. 6th ed. Boston: Little, Brown and Co.; 1964. p114.
3. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991;83:778-786.
4. Stevenson LW, Steimle AE, Fonarow G, Kermani M, Kermani D, Hamilton MA, Moriguchi JD, Walden J, Tillisch JH, Drinkwater DC, Laks H. Improvement in exercise capacity of candidates awaiting heart transplantation. J Am Coll Cardiol 1995;25:163-170.
5. Green P, Lund LH, Mancini D. Comparison of peak exercise oxygen consumption and the Heart Failure Survival Score for predicting prognosis in women versus men. Am J Cardiol 2007;99:399-403.
6. Olsson LG, Swedberg K, Clark AL, Witte KK, Cleland JGF. Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review. Eur Heart J 2005;26:778-793.
7. Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, Berman LB. The 6 min walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985;132:919-923.
8. Lipkin DP, Scriven AJ, Crake T, Poole-Wilson PA. Six minute walking test for assessing exercise capacity in chronic heart failure. Br Med J (Clin Res Ed) 1986; 292:653-655.
9. Poole-Wilson PA. The 6 min walk. A simple test with clinical application. Eur Heart J 2000;21:507-508.
10. Demers C, McKelvie RS, Negassa A, Yusuf S. Reliability, validity, and responsiveness of the six-minute walk test in patients with heart failure. Am Heart J 2001; 142:698-703.
11. Bittner V, Weiner DH, Yusuf S, Rogers WJ, McIntyre KM, Bangdiwala SI, Kronenberg MW, Kostis JB, Kohn RM, Guillotte M et al. Prediction of mortality and morbidity with a 6 min walk test in patients with left ventricular dysfunction. SOLVD Investigators. JAMA 1993;270:1702-1707.
12. Zile MR, Bennett TD, St John Sutton M, Cho YK, Adamson PB, Aaron MF, Aranda JM, Abraham WT, Smart FW, Stevenson LW, Kueffer FJ, Bourge RC. Transition from chronic compensated to acute decompensated heart failure: pathophysiologic insights obtained from continuous monitoring of intracardiac pressures. Circulation 2008;118:1433-1441.
13. Ohlsson A, Nordlander R, Bennett T, Bitkover C, Kjellstrom B, Lee B, Ryden L. Continuous ambulatory haemodynamic monitoring with an implantable system. The feasibility of a new technique. Eur Heart J 1998;19:174-184.
14. Magalski A, Adamson P, Gadler F, Boehm M, Steinhaus D, Reynolds D, Vlach K, Linde C, Cremers B, Sparks B, Bennett T. Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: a multicenter, 12-month follow-up study of patients with chronic heart failure. J Card Fail 2002;8:63-70.
15. Adamson PB, Magalski A, Braunschweig F, Bohm M, Reynolds D, Steinhaus D, Luby A, Linde C, Ryden L, Cremers B, Takle T, Bennett T. Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol 2003;41:565-571.
16. Braunschweig F, Linde C, Eriksson MJ, Hofman-Bang C, Ryden L. Continuous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure. Eur Heart J 2002;23:59-69.
17. Bourge RC, Abraham WT, Adamson PB, Aaron MF, Aranda JM Jr, Magalski A, Zile MR, Smith AL, Smart FW, O'shaughnessy MA, Jessup ML, Sparks B, Naftel DL, Stevenson LW. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol 2008;51:1073-1079.
18. Ohlsson A, Steinhaus D, Kjellstrom B, Ryden L, Bennett T. Central hemodynamic responses during serial exercise tests in heart failure patients using implantable hemodynamic monitors. Eur J Heart Fail 2003;5:253-259.
19. Braunschweig F, Linde C. Continuous hemodynamic monitoring in heart failure. J Cardiovasc Electrophysiol 2002;13(Suppl. 1):S68-S72.
20. Bennett T, Kjellstrom B, Taepke R, Ryden L. Development of implantable devices for continuous ambulatory monitoring of central hemodynamic values in heart failure patients. Pacing Clin Electrophysiol 2005;28:573- 584.
21. Chuang PP, Wilson RF, Homans DC, Stone K, Bergman T, Bennett TD, Kubo SH. Measurement of pulmonary artery diastolic pressure from a right ventricular pressure transducer in patients with heart failure. J Card Fail 1996;2:41-46.
22. Ohlsson A, Bennett T, Nordlander R, Ryden J, Astrom H, Ryden L. Monitoring of pulmonary arterial diastolic pressure through a right ventricular pressure transducer. J Card Fail 1995;1:161-168.
23. Reynolds DW, Bartelt N, Taepke R, Bennett TD. Measurement of pulmonary artery diastolic pressure from the right ventricle. J Am Coll Cardiol 1995;25: 1176-1182.
24. ATS Statement. Guidelines for the six-minute walk test. Am J Resp Crit Care Med. 2002;166:111-117.
25. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982; 14:377-381.
26. Tanaka H, Monahan KD, Seals DR. Age-predicted maximal heart rate revisited. J Am Coll Cardiol 2001;37:153-156.
27. Mortara A, La Rovere MT, Pinna GD, Maestri R, Capomolla S, Cobelli F. Nonselective beta-adrenergic blocking agent, carvedilol, improves arterial baroflex gain and heart rate variability in patients with stable chronic heart failure. J Am Coll Cardiol 2000;36:1612-1618.
28. La Rovere MT, Bersano C, Gnemmi M, Specchia G, Schwartz PJ. Exercise-induced increase in baroreflex sensitivity predicts improved prognosis after myocardial infarction. Circulation 2002;106:945-949.
29. Szlachcic J, Massie BM, Kramer BL, Topic N, Tubau J. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol 1985;55:1037-1042.
30. Zugck C, Kruger C, Durr S, Gerber SH, Haunstetter A, Hornig K, Kubler W, Haass M. Is the 6 min walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy? Eur Heart J 2000;21:540-549.
31. La Rovere MT, Pinna GD, Maestri R, Mortara A, Capomolla S, Febo O, Ferrari R, Franchini M, Gnemmi M, Opasich C, Riccardi PG, Traversi E, Cobelli F. Shortterm heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 2003;107:565-570.
32. Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, Baig W, Flapan AD, Cowley A, Prescott RJ, Neilson JM, Fox KA. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 1998;98:1510-1516.
33. Hjalmarson A. Significance of reduction in heart rate in cardiovascular disease. Clin Cardiol 1998;21(Suppl. 2):II3-II7.
34. Sutcliffe PD, Aaronson KD, Cody RJ, Koelling TM. Impact of serial changes in cardiac hemodynamics on exercise performance in patients with heart failure due to ischemic and nonischemic cardiomyopathy. Am J Cardiol 2003;91:164-168.